Your activity: 123 p.v.
Why UpToDate?
What's New
Patient Education
Calculators
Drug interactions
Subscribe
Log In
< Back
Approach to managing increased risk for cardiovascular disease in patients with severe mental illness
First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects
Guidelines for prescribing clozapine in schizophrenia
Metabolic syndrome in patients with severe mental illness: Epidemiology, contributing factors, pathogenesis, and clinical implications
Second-generation antipsychotic medications: Pharmacology, administration, and side effects
Assertive community treatment for patients with severe mental illness
Brief psychotic disorder
Delusional disorder
Delusional infestation: Epidemiology, clinical presentation, assessment and diagnosis
First episode psychosis
Lifestyle interventions for obesity and overweight patients with severe mental illness
Modifiable risk factors for cardiovascular disease in patients with severe mental illness
Postpartum psychosis: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis
Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation
Psychosis in adults: Initial management
Treatment of delusional infestation
Treatment of postpartum psychosis
Anxiety in schizophrenia
Depression in schizophrenia
Evaluation and management of treatment-resistant schizophrenia
Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugs
Psychosocial interventions for schizophrenia in adults
Schizophrenia in adults: Clinical manifestations, course, assessment, and diagnosis
Schizophrenia in adults: Epidemiology and pathogenesis
Schizophrenia in adults: Maintenance therapy and side effect management
Supported employment for patients with severe mental illness